

(Sharecast News) - Shield Therapeutics announced on Friday that it has secured a $10m investment from its largest shareholder, AOP Health Internationa...


(Alliance News) - Shield Therapeutics PLC on Thursday said it remains on track to meet its full-year revenue covenant target following strong sales of...


(Alliance News) - Shield Therapeutics PLC on Tuesday said it has strengthened its financial foundation in the hope of becoming cash flow positive by t...


(Sharecast News) - Shield Therapeutics reported a strong third-quarter performance for its iron deficiency treatment Accrufer in the US on Tuesday, ac...


(Sharecast News) - Shield Therapeutics announced promising results from its phase three paediatric clinical trial for 'Accrufer' and 'Ferracru', or fe...


(Alliance News) - Stock prices in London were lower at midday on Wednesday, despite positive service sector data, as the market continued to process a...


(Alliance News) - Shield Therapeutics PLC said on Wednesday that its revenue had multiplied threefold, but an increased cost of sales after its US exp...


(Alliance News) - The following stocks are the leading risers and fallers on AIM on Wednesday.